GENDER DISPARITY AND REAL-LIFE PRACTICE SETTING DIFFERENCES IN ACTUAL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B MEETING CRITERIA FOR ANTIVIRAL THERAPY

被引：0
|
作者：
Kim, L. H. [1 ]
Nguyen, V. G. [2 ]
Trinh, H. N. [2 ,3 ]
Li, J. [4 ]
Zhang, J. Q. [5 ]
Nguyen, M. [1 ]
机构：
[1] Stanford Univ, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[2] Pacific Hlth Fdn, San Jose, CA USA
[3] San Jose Gastroenterol, San Jose, CA USA
[4] Palo Alto Med Fdn, Gastroenterol, Mountain View, CA USA
[5] Chinese Hosp, San Francisco, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60033-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O31
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [31] Outcomes of Patients With Chronic Hepatitis B Who Do Not Meet Criteria for Antiviral Treatment at Presentation
    Yapali, Suna
    Talaat, Nizar
    Fontana, Robert J.
    Oberhelman, Kelly
    Lok, Anna S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 193 - U275
  • [32] Outcome of Chronic Hepatitis B Patients Who Do Not Meet Criteria for Antiviral Treatment At Presentation
    Yapali, Suna
    Talaat, Nizar
    Fontana, Robert J.
    Conjeevaram, Hari
    Oberhelman, Kelly
    Lok, Anna S.
    GASTROENTEROLOGY, 2014, 146 (05) : S962 - S962
  • [33] Results of sofosbuvir-based combination therapy for chronic hepatitis C cohort of Indian patients in real-life clinical practice
    Sood, Ajit
    Midha, Vandana
    Mahajan, Ramit
    Narang, Vikram
    Mehta, Varun
    Wander, Praneet
    Sharma, Suresh
    Kaur, Kirandeep
    Singh, Dharmatma
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 894 - 900
  • [34] PERSISTENCE TO ENTECAVIR TREATMENT FOR CHRONIC HEPATITIS B IN A REAL-LIFE SETTING: 2 YEAR RESULTS OF A GERMAN PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY
    Petersen, J.
    Wilke, T.
    Mauss, S.
    Heyne, R.
    Herold, C.
    Wiese, M.
    Boeker, K.
    Pichl, T.
    Meier, A.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S593 - S594
  • [35] Effectiveness and potential drug interactions in antiviral therapy for the treatment of chronic hepatitis C: real-life data from a specialized center in southern Brazil
    Schwambach, Karin Hepp
    Blatt, Carine Raquel
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 57
  • [36] Real-life data of hepatitis C treatment with direct acting antiviral therapy in persons injecting drugs or on opioid substitution therapy
    Pfaeffle, M.
    Duenkelmann, S.
    Boesecke, C.
    Rockstroh, J. k.
    Schwarze-Zander, C.
    INFECTION, 2024,
  • [37] Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
    Lee, Minjong
    Chung, Goh Eun
    Lee, Jeong-Hoon
    Oh, Sohee
    Nam, Joon Yeul
    Chang, Young
    Cho, Hyeki
    Ahn, Hongkeun
    Cho, Young Youn
    Yoo, Jeong-ju
    Cho, Yuri
    Lee, Dong Hyeon
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 (05) : 1556 - 1569
  • [38] PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE TO PEGYLATED INTERFERON THERAPY IN CHRONIC HEPATITIS B : A REAL-LIFE STUDY
    Purnomo, Hery Djagat
    Permatadewi, Cecilia Oktaria
    Hutami, Hesti Triwahyu
    Prasetyo, Agung
    Indiarso, Didik
    Hirlan, Hirlan
    HEPATOLOGY, 2020, 72 : 493A - 493A
  • [39] Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C
    Vukotic, Ranka
    Gamal, Nesrine
    Andreone, Pietro
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (02) : 151 - 156
  • [40] First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
    Pol, S.
    Lampertico, P.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 377 - 386
12345